ES2194104T3 - Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos. - Google Patents

Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.

Info

Publication number
ES2194104T3
ES2194104T3 ES96917093T ES96917093T ES2194104T3 ES 2194104 T3 ES2194104 T3 ES 2194104T3 ES 96917093 T ES96917093 T ES 96917093T ES 96917093 T ES96917093 T ES 96917093T ES 2194104 T3 ES2194104 T3 ES 2194104T3
Authority
ES
Spain
Prior art keywords
mammals
hearing
loss
selegyline
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96917093T
Other languages
English (en)
Inventor
William W Ruehl
David R Stevens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deprenyl Animal Health Inc
Original Assignee
Deprenyl Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deprenyl Animal Health Inc filed Critical Deprenyl Animal Health Inc
Application granted granted Critical
Publication of ES2194104T3 publication Critical patent/ES2194104T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE UTILIZA LA SELEGILINA Y LAS FORMAS ANALOGAS FARMACEUTICAMENTE ACEPTABLES DE LA MISMA COMO TRATAMIENTOS PARA LA PERDIDA DE AUDICION EN MAMIFEROS, EN ESPECIAL PERROS.
ES96917093T 1995-06-07 1996-06-03 Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos. Expired - Lifetime ES2194104T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/475,186 US5561163A (en) 1990-08-31 1995-06-07 Treating hearing loss with deprenyl

Publications (1)

Publication Number Publication Date
ES2194104T3 true ES2194104T3 (es) 2003-11-16

Family

ID=23886552

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96917093T Expired - Lifetime ES2194104T3 (es) 1995-06-07 1996-06-03 Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.

Country Status (9)

Country Link
US (1) US5561163A (es)
EP (1) EP0831798B1 (es)
JP (1) JP3094305B2 (es)
AT (1) ATE234614T1 (es)
AU (1) AU693704B2 (es)
CA (1) CA2221255C (es)
DE (1) DE69626816T2 (es)
ES (1) ES2194104T3 (es)
WO (1) WO1996040094A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005102345A1 (en) * 2004-03-30 2005-11-03 Alcon, Inc. Use of rho kinase inhibitors in the treatment of hearing loss, tinnitus and improving body balance
CA2569238A1 (en) 2004-06-01 2005-12-15 F. Hoffmann-La Roche Ag Monoamine reuptake inhibitor
CN108865972B (zh) 2013-03-14 2022-07-29 布里格海姆妇女医院公司 一种细胞培养溶液
KR20230019500A (ko) 2014-09-03 2023-02-08 더 브리검 앤드 우먼즈 하스피털, 인크. 청력 손실의 치료를 위해 내이 털세포를 생성하기 위한 조성물, 시스템, 및 방법
WO2017120543A1 (en) 2016-01-08 2017-07-13 Massachusetts Institute Of Technology Production of differentiated enteroendocrine cells and insulin producing cells
US10201540B2 (en) 2016-03-02 2019-02-12 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I
US11260130B2 (en) 2016-03-02 2022-03-01 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV
US10213511B2 (en) 2016-03-02 2019-02-26 Frequency Therapeutics, Inc. Thermoreversible compositions for administration of therapeutic agents
EP3562827A1 (en) 2016-12-30 2019-11-06 Frequency Therapeutics, Inc. 1h-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells
WO2020037326A1 (en) 2018-08-17 2020-02-20 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by downregulating foxo
AU2019321641A1 (en) 2018-08-17 2021-04-15 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by upregulating Jag-1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA871155A (en) * 1971-05-18 Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation
HU187775B (en) * 1982-07-14 1986-02-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu New process for producing propargile-amines of pharmaceutical activity
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
US4916151A (en) * 1985-12-05 1990-04-10 Merrell Dow Pharmaceuticals Inc. Method of treating parkinson's syndrome
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
SE9301112D0 (sv) * 1993-04-02 1993-04-02 Orion-Yhtymae Oy A new composition

Also Published As

Publication number Publication date
WO1996040094A1 (en) 1996-12-19
AU693704B2 (en) 1998-07-02
JPH10510843A (ja) 1998-10-20
AU5977296A (en) 1996-12-30
CA2221255A1 (en) 1996-12-19
DE69626816T2 (de) 2004-02-05
CA2221255C (en) 2005-11-08
EP0831798B1 (en) 2003-03-19
US5561163A (en) 1996-10-01
JP3094305B2 (ja) 2000-10-03
DE69626816D1 (de) 2003-04-24
EP0831798A1 (en) 1998-04-01
ATE234614T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
ES2162937T3 (es) Preparado combinado para su aplicacion en enfermedades inmunologicas.
FI956014A0 (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
BR9814040A (pt) Agudo no pulmão com fibrose com antagonistas de avb6
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
AR003119A1 (es) Composicion farmaceutica para tratar infecciones virosicas o inhibir el crecimiento de tumores o canceres que comprenden una mezcla de un n- clorofenilcarbamato o un n- clorofeniltiocarbamato y un n- fosfonoglicina y uso de dicha composicion farmaceutica para la manufactura de un medicamento para tratar infecciones virosicas o inhibir el crecimiento de tumores o canceres
AR008799A1 (es) Composicion de vacuna para prevenir o tratar el paludismo; uso de dicha composicion para elaborar medicamentos y metodo para dicha profilaxis y dichotratamiento
CA2148988A1 (fr) Utilisation d'extraits de bacteries filamenteuses comme agents cosmetiques contre le vieillissement cutane
AR016981A2 (es) Polipeptidos sinteticos
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
ES2167678T3 (es) Tratamiento y profilaxis de la pancreatitis.
TR199900505T2 (es)
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ATE260559T1 (de) Sordarinderivate
BR0012006A (pt) Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr
ES2196769T3 (es) Uso topico de loperamide para el tratamiento de infecciones microbianas.
ES2171080T3 (es) Composicion para la mejora de la fertilidad y su aplicacion.
ES2160969T3 (es) Derivados anticonvulsivos utiles en el tratamiento de la psoriasis.
ES2165020T3 (es) Monohidrato de famciclovir.
ES2141923T3 (es) Uso hipocolesterolemico, antiaterosclerotico e hipotrigliceridemico de derivados aminoacetilmercapto.
ITRM930154A0 (it) Uso di terbinafina per il trattamento terapeutico della pneumocistosi.
ES2167942T3 (es) Empleo de 2-aminotetralinas 6,7-sustituidas apropiadas para la preparacion de una composicion farmaceutica para el tratamiento terapeutico de patologias inflamatorias y/o autoinmunes.